These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
612 related articles for article (PubMed ID: 26381381)
1. Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy. Singh NN; Lee BM; DiDonato CJ; Singh RN Future Med Chem; 2015; 7(13):1793-808. PubMed ID: 26381381 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes. Singh RN; Singh NN Adv Neurobiol; 2018; 20():31-61. PubMed ID: 29916015 [TBL] [Abstract][Full Text] [Related]
3. RNA in spinal muscular atrophy: therapeutic implications of targeting. Singh RN; Seo J; Singh NN Expert Opin Ther Targets; 2020 Aug; 24(8):731-743. PubMed ID: 32538213 [TBL] [Abstract][Full Text] [Related]
4. Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions. Singh NN; Lee BM; Singh RN Ann N Y Acad Sci; 2015 Apr; 1341():176-87. PubMed ID: 25727246 [TBL] [Abstract][Full Text] [Related]
5. Nusinersen in the Treatment of Spinal Muscular Atrophy. Goodkey K; Aslesh T; Maruyama R; Yokota T Methods Mol Biol; 2018; 1828():69-76. PubMed ID: 30171535 [TBL] [Abstract][Full Text] [Related]
7. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Singh NK; Singh NN; Androphy EJ; Singh RN Mol Cell Biol; 2006 Feb; 26(4):1333-46. PubMed ID: 16449646 [TBL] [Abstract][Full Text] [Related]
8. New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand? Chen TH Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392694 [TBL] [Abstract][Full Text] [Related]
9. Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape. Wood MJA; Talbot K; Bowerman M Hum Mol Genet; 2017 Oct; 26(R2):R151-R159. PubMed ID: 28977438 [TBL] [Abstract][Full Text] [Related]
10. How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy. Singh NN; Howell MD; Androphy EJ; Singh RN Gene Ther; 2017 Sep; 24(9):520-526. PubMed ID: 28485722 [TBL] [Abstract][Full Text] [Related]
11. Splicing-Correcting Therapy for SMA. Wan L; Dreyfuss G Cell; 2017 Jun; 170(1):5. PubMed ID: 28666123 [TBL] [Abstract][Full Text] [Related]
12. A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. Singh NN; Shishimorova M; Cao LC; Gangwani L; Singh RN RNA Biol; 2009; 6(3):341-50. PubMed ID: 19430205 [TBL] [Abstract][Full Text] [Related]